Experience Recombinant Human Interleukin-2/il-2 Protein (his Tag)(active) Now 40% Cheaper [15Ryqr2Z]

Experience Recombinant Human Interleukin-2/il-2 Protein (his Tag)(active) Now 40% Cheaper [15Ryqr2Z]

Discover the power of recombinant human interleukin-2 (IL-2) protein, a vital component in the immune system's response to various challenges. This active protein, derived from HEK293 cells, offers a reliable solution for research and therapeutic applications. Its unique His Tag ensures easy detection and purification, making it a preferred choice for scientists and healthcare professionals.

Key Product Features

The recombinant human interleukin-2 protein stands out for its high purity, exceeding 95%, as confirmed by reducing SDS-PAGE. This purity ensures the reliability and accuracy of your research outcomes. With an observed molecular weight ranging from 14-18 kDa and a calculated molecular weight of 16.4 kDa, this protein offers consistent performance. The bio-activity of this recombinant IL-2 is measured at ≥1×10⁷ IU/mg, demonstrating its potent immune-regulatory capabilities. Here are some of its key features:

• Purity: > 95% as determined by reducing SDS-PAGE.
• Bio-activity: ≥1×10⁷ IU/mg, measured in a cell proliferation assay.
• Expression Host: HEK293 Cells.

Applications and Benefits

The recombinant human interleukin-2 protein is a versatile tool for a wide range of applications in immunology, oncology, and cell biology research. Its ability to stimulate growth and differentiation of various immune cells, such as T-cells, B-cells, and NK cells, makes it an essential component in understanding immune responses and developing novel therapeutic strategies. This product is particularly beneficial for:

• Immunology Research: Studying T-cell proliferation, B-cell activation, and NK cell function.
• Oncology Research: Investigating the role of interleukin-2 in cancer treatment and immunotherapy.
• Cell Biology Research: Examining the interactions between interleukin-2 and its receptors in various cell types.